官方服务：
资源简介：
Immunotherapy Targets in Tumors
应用场景：
创建时间：
2014-03-14
相关数据集
DataSheet4_A systematic pan-cancer analysis reveals the clinical prognosis and immunotherapy value of C-X3-C motif ligand 1 (CX3CL1).ZIP
It is now widely known that C-X3-C motif ligand 1 (CX3CL1) plays an essential part in the process of regulating pro-inflammatory cells migration across a wide range of inflammatory disorders, includin
NIAID Data Ecosystem00
CyTOF data of MC38 tumor-bearing mice treated with aPD-1-mEry
Splenocytes were isolated from MC38 tumor-bearing C57BL/6-hPD-1 mice receiving 2 treatments of IgG4-mEry, αPD-1, or αPD-1-mEry.
NIAID Data Ecosystem00
Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemiplimab.
NIAID Data Ecosystem10
A microRNA-regulated transcriptional state defines intratumoral CD8+T cells that respond to immunotherapy. A microRNA-regulated transcriptional state defines intratumoral CD8+T cells that respond to immunotherapy
Rising rates of advanced-stage colorectal cancer (CRC) and poor survival rates necessitate effective therapeutic options. Immune checkpoint inhibition (ICI), specifically anti-PD-1 therapy, shows pote
NIAID Data Ecosystem00
